U.S., July 3 -- ClinicalTrials.gov registry received information related to the study (NCT07681375) titled 'Evaluation of Basal Insulin Initialization and Titration in People With Type 2 Diabetes Wearing a Dexcom G6 Sensor' on May 18.
Brief Summary: To evaluate the feasibility of the DexBasal Study System
Study Start Date: April 11, 2023
Study Type: INTERVENTIONAL
Condition:
Type 2 Diabetes
Intervention:
DRUG: Basal insulin
daily basal insulin dose
DEVICE: Dexcom Continuous Glucose Monitoring (CGM)
Dexcom Continuous Glucose Monitoring (CGM) Sensor
Recruitment Status: ACTIVE_NOT_RECRUITING
Sponsor: DexCom, Inc.
Disclaimer: Curated by HT Syndication....